Methestrol dipropionate
Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Meprane Dipropionate |
| Other names | Methoestrol dipropionate; Metestrol dipropionate; Promethestrol dipropionate; Promethoestrol dipropionate; Dimethylhexestrol dipropionate |
| Drug class | Nonsteroidal estrogen; Estrogen ester |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID |
|
| ChemSpider |
|
| UNII |
|
| Chemical and physical data | |
| Formula | C26H34O4 |
| Molar mass | 410.554 g·mol−1 |
| 3D model (JSmol) |
|
| |
InChI
| |
Methestrol dipropionate or methoestrol dipropionate (brand name Meprane Dipropionate), also known as promethestrol dipropionate or promethoestrol dipropionate or as dimethylhexestrol dipropionate, is a synthetic nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that is or was used clinically.[1][2][3][4][5][6][7][8] It is the dipropionate form of methestrol (or promethestrol), which, in contrast to methestrol dipropionate, was never marketed.[3]
See also
- Benzestrol
- Dienestrol
- Fosfestrol
- Hexestrol
References
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 608–. ISBN 978-0-412-46630-4.
- ^ Brucker MC, King TL (8 September 2015). Pharmacology for Women's Health. Jones & Bartlett Learning. pp. 640–. ISBN 978-1-284-10811-8.
- ^ a b Ganellin CR, Triggle DJ (21 November 1996). Dictionary of Pharmacological Agents. Taylor & Francis. pp. 1298–. ISBN 978-0-412-46630-4.
- ^ Thomas JA, Keenan EJ (6 December 2012). Principles of Endocrine Pharmacology. Springer Science & Business Media. pp. 150–. ISBN 978-1-4684-5036-1.
- ^ Prasad A, Sinha AK (1985). Essential of Endocrinology and Reproductive Physiology. Allied Publishers. pp. 85–. GGKEY:HLNJ1BHUKW2.
- ^ Modell W (21 November 2013). Drugs in Current Use 1958. Springer. pp. 114–. ISBN 978-3-662-40303-7.
- ^ Dubin WR, Stolberg R (6 December 2012). Emergency Psychiatry for the House Officer. Springer Science & Business Media. pp. 155–. ISBN 978-94-011-6690-4.
- ^ Raspé G (22 October 2013). Hormones and Embryonic Development: Advances in The Biosciences. Elsevier Science. pp. 141–. ISBN 978-1-4831-5171-7.
- v
- t
- e
Estrogens and antiestrogens
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Estrogen receptor modulators
- Androgens and antiandrogens
- Progestogens and antiprogestogens
- List of estrogens
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
